Agilon Health (AGL) Enterprise Value (2021 - 2026)

Agilon Health (AGL) has 7 years of Enterprise Value data on file, last reported at -$231.4 million in Q1 2026.

• Quarterly Enterprise Value rose 36.96% year-over-year to -$231.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$231.4 million (up 36.96% YoY) and the FY2025 annual result came in at -$285.1 million, up 28.71% from the prior year.
• Enterprise Value climbed to -$231.4 million in Q1 2026, from -$285.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$231.4 million in Q1 2026 to a low of -$1.0 billion in Q1 2022.
• A 5-year average of -$553.1 million and a median of -$419.9 million in 2024 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2022 — Enterprise Value tumbled 870.11% — and 2024, when it soared 48.63%.
• Tracing AGL's Enterprise Value over 5 years: stood at -$877.8 million in 2022, then surged by 44.28% to -$489.2 million in 2023, then rose by 18.23% to -$400.0 million in 2024, then gained by 28.71% to -$285.1 million in 2025, then grew by 18.84% to -$231.4 million in 2026.
• The last three Enterprise Value figures came in at -$231.4 million (Q1 2026), -$285.1 million (Q4 2025), and -$310.9 million (Q3 2025), per Business Quant data.